Kliinisen patologian ja oikeuslääketieteen laitos
Department of Pathology and Forensic Medicine

Julkaisut 1992
Publications 1992

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aaltomaa S, Lipponen P. A review of prognostic factors in breast cancer.
2 Aaltomaa S et al. Does delay in fixation affect the mitosis counts in breast cancer biopsy specimens?
3 Aaltomaa S et al. Kliiniset ja histomorfometriset menetelmät rintasyövän ennusteen arvioinnissa.
4 Aaltomaa S et al. Mitotic indexes as prognostic predictors in female breast cancer.
5 Aaltomaa S et al. Histological assessment of the prognostic factors in female breast cancer.
6 Aaltomaa S et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer.
7 Aaltomaa S et al. Prediction of outcome after first recurrence of breast cancer.
8 Aaltomaa S et al. Prognostic factors after 5 years follow-up in female breast cancer.
9 Aaltomaa S et al. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymphnode-positive breast cancer.
10 Aaltomaa S et al. Prognostic factors in invasive lobular carcinoma of the breast.
11 Aaltomaa S et al. Prediction of outcome after recurrence of breast cancer.
12 Aaltomaa S et al. Prognostic factors after 5-years follow-up in female breast cancer.
13 Aaltomaa S et al. Prognostic value of nuclear morphometry and tumour proliferative activity in axillary lymph node positive breast cancer.
14 Aaltomaa S et al. Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
15 Aaltomaa S et al. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
16 Chang F et al. Human papillomavirus (HPV) involvemenmt in esophageal precancer lesions and squamous cell carcinomas as evidenced by microscopy and different DNA-techniques.
17 Chang F et al. Infectious agents in the etiology of esophageal cancer.
18 Chang F et al. Human papillomavirus infections in the respiratory tract.
19 Chang F et al. Investigation on the carcinogenic effects of coal tar pitch in rat respiratory tract by intratracheal instillations.
20 Collan Y et al. Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers: Evaluation of the grading efficiency of ploidy determination, DNA index, and S phase fraction.
21 Costa S et al. Detection of human papillomavirus infections in the male sexual partners of women attending an STD clinic in Bologna.
22 Eskelinen M. Rintasyövän kliininen diagnostiikka.
23 Eskelinen M et al. A decision support system to aid in predicting a recurrence of breast cancer; a prospective study of serum tumour markers TAG 12, CA 15-3 and MCA.
24 Eskelinen M et al. Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis.
25 Eskelinen M et al. A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.
26 Eskelinen M et al. Clinical diagnosis of acute appendicitis; a prospective study of patients with acute abdominal pain.
27 Eskelinen M et al. A computer based diagnostic score to aid in diagnosis of acute appendicitis; a prospective study of 1333 patients with acute abdominal pain.
28 Eskelinen M, Lipponen P. A review of prognostic factors in human pancreatic adenocarcinoma.
29 Eskelinen M et al. Breast cancer in young women: clinical, histological and morphometric prognostic factors.
30 Eskelinen M et al. DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer.
31 Eskelinen M et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors in female breast cancer.
32 Eskelinen M et al. Expression of tumour markers CA 50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
33 Eskelinen M et al. Nucleolar organizer regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
34 Eskelinen M et al. Primary malignant schwannoma of the small bowel.
35 Gulyás AI et al. Calretinin is present in non-pyramidal cells of the rat hippocampus-I. A new type of neuron specifically associated with the mossy fibre system.
36 Halasy K et al. GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus.
37 Halmekytö M et al. Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.
38 Heinonen O et al. JC virus (JCV) infection and Alzheimer`s disease. Reapprisal of the in situ hybridization data.
39 Hippeläinen M. Miehen kondylooma.
40 Johansson R. Hormones in cancer therapy.
41 Jolkkonen J et al. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
42 Jäkälä P et al. Continuous alpha-2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats.
43 Karjalainen J et al. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
44 Kataja V. Genital human papillomavirus (HPV) infections. Prevalence, incidence, risk factors and prognosis.
45 Kataja V et al. Prognostic factors in cervical human papillomavirus infections.
46 Kellokoski J. Human papillomavirus (HPV) infections of the oral cavity in women with genital HPV infections.
47 Kellokoski J et al. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections.
48 Kellokoski J et al. Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections.
49 Lassus J et al. Comparison of four in situ hybridization methods, based on digoxigenin- and biotin-labelled probes, in detecting HPV DNA in male condylomata acuminata.
50 Lassus J et al. A comparison of histopathologic diagnosis and the demonstration of human papillomavirus-specific DNA and proteins in penile warts.
51 Lipponen P. A review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer.
52 Lipponen P. A review of mitotic indices as indicators of malignancy in human tumours.
53 Lipponen P. Histological and quantitative prognostic factors in transitional cell bladder cancer treated by cystectomy.
54 Lipponen P. Virtsarakon syövän uudet ennustetekijät.
55 Lipponen P et al. The changing importance of prognostic factors in breast cancer during a long-term follow-up.
56 Lipponen P, Collan Y. Simple quantitation of immunohistochemical staining positivity in microscopy.
57 Lipponen P, Eskelinen M. Argyrophilic nucleolar organiser regions (Ag-NORs) in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic value.
58 Lipponen P, Eskelinen M. Cell proliferation of transitional cell bladder cancer determined by PCNA/Cyclin immunostaining. A histopathological description.
59 Lipponen P, Eskelinen M. Cell proliferation of transitional cell bladder tumours determined by PCNA/Cyclin immunostaining and its prognostic value.
60 Lipponen P et al. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours with special reference to mitotic frequency.
61 Lipponen P et al. Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two grade classification system for TCC based on mitotic index.
62 Lipponen P et al. Prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods.
63 Lipponen P et al. Sex steroid receptors, DNA ploidy and S-phase fraction as determinants of the risk of relapse and death of female breast cancer.
64 Lipponen P et al. Sex steroid receptors, S-phase fraction and DNA ploidy ad determinants of the risk of relapse and death of female breast cancer.
65 Lipponen P et al. The use of immunohisto-chemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
66 Lipponen P et al. DNA ploidy, S-phase fraction and mitotic indices as predictors of female breast cancer.
67 Lipponen PK. Ag-NOR protein area in transitional cell bladder cancer as measured by image analysis.
68 Lipponen PK. Mitotic indices as indicators of malignancy in human tumours.
69 Lipponen PK. Review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer.
70 Lipponen PK et al. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder tumours.
71 Lipponen PK et al. Prediction of superficial bladder cancer by nuclear image analysis.
72 Miettinen R, Freund TF. Convergence and segregation of septal and median raphe inputs onto different subsets of hippocampal inhibitory interneurons.
73 Miettinen R, Freund TF. Neuropeptide Y-containing interneurons in the hippocampus receive synaptic input from median raphe and GABAergic septal afferents.
74 Miettinen R et al. Calretinin is present in non-pyramidal cells of the rat hippocampus-II. Co-existence with other calcium binding proteins and GABA.
75 Nuutinen P et al. Low power interstitial hyperthermia in the treatment of ductal carcinoma of the pancreas: an experimental study with Syrian golden hamsters.
76 Pasanen P et al. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; Results from a prospective study.
77 Paukkonen K et al. The development of a manifest psoriatic lesion is linked with the invasion of CD8+ T-cells and CD11c+ macrophages into the epidermis.
78 Riekkinen P Jr et al. Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats.
79 Riekkinen P Jr et al. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits.
80 Riekkinen P Jr et al. Neurophysiological consequences of combined cholinergic and noradrenergic lesions.
81 Riekkinen P Jr et al. DSP-4, a noradrenergic neurotoxin, produces more severe biochemical and functional deficits in aged than young rats.
82 Rouhiainen H et al. Xanthogranuloma Juvenile - a rare cause of orbital swelling in adulthood.
83 Servomaa K et al. Transformation of cells irradiated with Chernobyl-released and artificial hot particles.
84 Seveus L et al. Time-resolved fluorescence imaging of europium chelate label in immunohistochemistry and in situ hybridization.
85 Soininen H et al. Amyloid beta-protein deposition in skin of patients with dementia.
86 Syrjänen K. The long-term consequences of genital HPV infections in women. Editorial.
87 Syrjänen K et al. Natural history of cervical HPV lesions with special emphasis on the biologic relevance of the bethesda system.
88 Syrjänen KJ. Does human papillomavirus (HPV) cause cervical cancer?
89 Syrjänen KJ. Papilloma virus and cervical cancer.
90 Syrjänen KJ. The molecular biology of human papillomavirus.
91 Syrjänen KJ. The normal cervix. Concept of the transformation zone.
92 Syrjänen KJ. Cytology and histology of cervical lesions.
93 Syrjänen KJ. Genital human papillomavirus (HPV) infections and their associations with squamous cell cancer: reapprisal of the morphologic, epidemiologic and DNA data.
94 Syrjänen KJ. Genital human papilloma virus infections in HIV-infected males and females.
95 Syrjänen S. Viral infections in oral mucosa.
96 Syrjänen S. Viral gene detection by in situ hybridization.
97 Syrjänen S et al. Polymerase chain reaction for producing biotinylated human papillomavirus DNA probes for in situ hybridization.
98 Syrjänen S et al. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
99 Syrjänen S, Syrjänen K. Human papillomavirus infections of the genital tract: clinical significance and diagnosis by polymerase chain reaction.
100 Tervahauta A et al. Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies.
101 Tosi P et al. Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV): quantitative data and cytokeratin expression.
102 Tuppurainen K et al. Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction.
103 Vanninen E et al. Gammakuvaus luustometastasoinnin arvioinnissa.
104 Wikström A et al. The acetic acid test in evaluation of subclinical genital papillomavirus infection (GPVI). A comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings.
105 Yang XM et al. Sapphire probe laser ablation of human arteries with CO2 gas and saline perfusion: the effect of flow rate, lasing power and lasing time.
106 Yliskoski M et al. Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.

Kliinisen patologian ja oikeuslääketieteen laitos Department of Pathology and Forensic Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008